These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7563822)

  • 41. [Criteria to hepatitis C treatment response].
    Levi D; Tanno H; Descalzi V
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S50-2; discussion S74-82. PubMed ID: 16862861
    [No Abstract]   [Full Text] [Related]  

  • 42. [Antiviral preparations in the therapy of chronic viral hepatitis].
    Geller LI
    Ter Arkh; 1990; 62(11):15-9. PubMed ID: 1710074
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Incidence of hepatocellular carcinoma in patients treated with interferon].
    Yokosuka O; Omata M
    Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):805-9. PubMed ID: 7563880
    [No Abstract]   [Full Text] [Related]  

  • 44. Hepatitis C: who should we be treating?
    Kirchner JT
    Am Fam Physician; 1999 Jan; 59(2):273-4, 277. PubMed ID: 9930123
    [No Abstract]   [Full Text] [Related]  

  • 45. The interferon sensitivity determining region: all hepatitis C virus isolates are not the same.
    Herion D; Hoofnagle JH
    Hepatology; 1997 Mar; 25(3):769-71. PubMed ID: 9049233
    [No Abstract]   [Full Text] [Related]  

  • 46. Should treatment of hepatitis C in HIV-seropositive and HIV-seronegative patients with hemophilia include induction doses of interferon?
    McGovern B; Bica I
    Clin Infect Dis; 2003 Aug; 37(3):463-4; author reply 464-5. PubMed ID: 12884180
    [No Abstract]   [Full Text] [Related]  

  • 47. [Antiviral therapy of hepatitis C].
    Erhardt A; Petry W; Ebel M; Jablonowski H; Heintges T; Häussinger D
    Z Gastroenterol; 2000 Mar; 38(3):259-69. PubMed ID: 10768250
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Selection for treatment of hepatitis C co-infected patients for ].
    Findor J; Bessone F; Corti M
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S48-50; discussion S74-82. PubMed ID: 16862860
    [No Abstract]   [Full Text] [Related]  

  • 49. Focus on hepatitis. Increased RBV dose for better HCV treatment response.
    Bernard EJ
    IAPAC Mon; 2006 Jan; 12(1):18. PubMed ID: 17249131
    [No Abstract]   [Full Text] [Related]  

  • 50. Hepatitis C: a hidden, growing problem.
    Kennedy M
    WMJ; 2000 Aug; 99(5):24-5. PubMed ID: 11043065
    [No Abstract]   [Full Text] [Related]  

  • 51. Hepatitis C, interferon, and risk of rejection after liver transplantation.
    Samuel D
    Liver Transpl; 2004 Jul; 10(7):868-71. PubMed ID: 15237370
    [No Abstract]   [Full Text] [Related]  

  • 52. [Effective continuous hemofiltration and plasma exchange for the treatment of subacute type fulminant hepatic failure].
    Ogawa R; Kishikawa T; Kudo J; Inaba S; Takamatsu Y; Hirata Y; Yoshimatsu H; Ishibashi H; Taniyama T; Zaitsu A
    Fukuoka Igaku Zasshi; 1992 Aug; 83(8):338-42. PubMed ID: 1398429
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Hepatitis C today].
    Bourlière M
    Soins; 1999 Dec; (641):33-6. PubMed ID: 10857435
    [No Abstract]   [Full Text] [Related]  

  • 54. Advisory panel: expand hepatitis therapy to HIV/AIDS patients.
    AIDS Policy Law; 2002 Jul; 17(12):2. PubMed ID: 12134793
    [No Abstract]   [Full Text] [Related]  

  • 55. Does iron reduction improve sustained viral responses to interferon monotherapy in hepatitis C patients? Maybe, but is this the right question?
    Shedlofsky SI
    Am J Gastroenterol; 2002 May; 97(5):1093-6. PubMed ID: 12014712
    [No Abstract]   [Full Text] [Related]  

  • 56. Newly acquired hepatitis C--many hurdles from diagnosis until treatment initiation.
    Wiegand J
    J Gastroenterol Hepatol; 2008 Dec; 23(12):1782-4. PubMed ID: 19120870
    [No Abstract]   [Full Text] [Related]  

  • 57. Interferon therapy in hepatitis C virus (HCV) induced chronic hepatitis: clinical significance of pretreatment with glycyrhizine.
    Fujisawa K
    Trop Gastroenterol; 1991; 12(4):176-9. PubMed ID: 1726032
    [No Abstract]   [Full Text] [Related]  

  • 58. Hepatitis C and pregnancy.
    Bianca S
    Aust N Z J Obstet Gynaecol; 2004 Aug; 44(4):375; author reply 375. PubMed ID: 15282023
    [No Abstract]   [Full Text] [Related]  

  • 59. Hepatitis treatment in developing countries.
    Smeeth L
    Lancet; 1998 Nov; 352(9141):1711-2. PubMed ID: 9853475
    [No Abstract]   [Full Text] [Related]  

  • 60. Re: Possible prevention of fulminant hepatic failure in four children with acute severe hepatitis.
    Iorio R; Spagnuolo MI
    J Gastroenterol; 2005 Sep; 40(9):912; author reply 912-3. PubMed ID: 16211350
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.